WBIW.com News - state

Brought to you by WBIW News and Network Indiana

FDA Approves New Eli Lilly Diabetes Drug

Last updated on Tuesday, May 3, 2011

(UNDATED) - The Food and Drug Administration has approved a diabetes drug created in a collaborative effort between Eli Lilly and Connecticut-based Boehringer Ingelheim Pharmaceuticals.

Tradjenta lowers blood sugar in a glucose-dependent manner by increasing incretin levels.

The drug is approved to be used by people with type 2 diabetes in conjunction with diet and exercise.

1340 AM WBIW welcomes comments and suggestions by calling 812.277.1340 during normal business hours or by email at comments@wbiw.com

© Ad-Venture Media, Inc. All Rights Reserved.

Click here to go back to previous page